Point State Capital LP Amicus Therapeutics, Inc. Transaction History

Point State Capital LP

  • $5.69 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 15, 2018
SELL
$13.76 - $17.12 $14.9 Million - $18.6 Million
-1,085,900 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$12.51 - $16.24 $7.27 Million - $9.44 Million
-581,000 Reduced 34.86%
1,085,900 $15.6 Million
Q3 2017

Nov 14, 2017
BUY
$11.74 - $15.78 $19.6 Million - $26.3 Million
1,666,900
1,666,900 $25.1 Million

Others Institutions Holding FOLD

# of Institutions
273
Shares Held
325M
Call Options Held
841K
Put Options Held
353K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.81B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Point State Capital LP Portfolio

Follow Point State Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Point State Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email